Related Experiment Videos
Amyloid heart disease manifested by systemic arterial thromboemboli
R S Browne1, H Schneiderman, N Kayani
1Department of Medicine, University of Connecticut Health Center, Farmington 06030.
Chest
|July 1, 1992
Summary
Amyloid heart disease can lead to blood clots (cardiogenic thromboemboli) due to impaired blood flow and clotting abnormalities. This study revisits Virchow's triad to explain this rare but serious complication.
Area of Science:
- Cardiology
- Hematology
- Pathophysiology
Background:
- Amyloid heart disease (AHD) is characterized by a stiff heart, impaired diastolic filling, and preserved systolic function.
- Cardiogenic thromboemboli are a rare complication in patients with AHD.
Observation:
- Two patients with AHD presented with cardiogenic thromboemboli.
- Investigation revealed contributing factors aligning with Virchow's triad: stasis, endothelial disturbance, and coagulability abnormalities.
Findings:
- The occurrence of thromboemboli in AHD appears to be multifactorial, resulting from the cumulative effects of stasis, endothelial dysfunction, and potential blood clotting disorders.
- This suggests a complex interplay of factors beyond the primary cardiac pathology.
Implications:
- Understanding the pathophysiologic basis of thromboemboli in AHD is crucial for effective patient management.
- Specific diagnostic workup and therapeutic strategies should be considered for AHD patients at risk for thromboembolic events.